3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: January 3, 2020
Period of Report: January 1, 2020
Accession Number: 0001104659-20-000974

View Document ↗ View on SEC.gov ↗